# A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)

> **NCT02121301** · PHASE2 · COMPLETED · sponsor: **Mitotech, SA** · enrollment: 91 (actual)

## Conditions studied

- Keratoconjunctivitis Sicca

## Interventions

- **DRUG:** Low Dose 0.155µg/mL SkQ1 ophthalmic solution
- **DRUG:** High Dose 1.55µg/mL SkQ1 ophthalmic solution
- **DRUG:** Placebo (Vehicle) opthalmic solution

## Key facts

- **NCT ID:** NCT02121301
- **Lead sponsor:** Mitotech, SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2020-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02121301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02121301, "A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02121301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*